Bisphosphonates in the treatment of skeletal metastases

被引：30

作者：

Conte, P

Coleman, R

机构：

[1] Univ Modena & Reggio Emilia, Dept Haematol & Oncol, Modena, Italy

[2] Weston Pk Hosp, Canc Res Ctr, Yorkshire Acad Unit Clin Oncol, Sheffield, S Yorkshire, England

来源：

SEMINARS IN ONCOLOGY | 2004年 / 31卷 / 05期

关键词：

D O I：

10.1053/j.seminoncol.2004.07.024

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：59 / 63

页数：5

共 46 条

[31] The anti-tumour activity of bisphosphonates [J].

Neville-Webbe, HL ;

Holen, I ;

Coleman, RE .

CANCER TREATMENT REVIEWS, 2002, 28 (06) :305-319

[32] DOUBLE-BLIND CONTROLLED TRIAL OF ORAL CLODRONATE IN PATIENTS WITH BONE METASTASES FROM BREAST-CANCER [J].

PATERSON, AHG ;

POWLES, TJ ;

KANIS, JA ;

MCCLOSKEY, E ;

HANSON, J ;

ASHLEY, S .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (01) :59-65

[33]

PAVLAKIS N, 2002, COCHRANE DB SYST REV, V1

[34] Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer [J].

Powles, T ;

Paterson, S ;

Kanis, JA ;

McCloskey, E ;

Ashley, S ;

Tidy, A ;

Rosenqvist, K ;

Smith, I ;

Ottestad, L ;

Legault, S ;

Pajunen, M ;

Nevantaus, A ;

Männistö, E ;

Suovuori, A ;

Atula, S ;

Nevalainen, J ;

Pylkkänen, L .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (15) :3219-3224

[35] Molecular mechanisms of action of bisphosphonates [J].

Rogers, MJ ;

Frith, JC ;

Luckman, SP ;

Coxon, FP ;

Benford, HL ;

Mönkkönen, J ;

Auriola, S ;

Chilton, KM ;

Russell, RGG .

BONE, 1999, 24 (05) :73S-79S

[36] Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: A phase III, double-blind, randomized trial - The zoledronic acid lung cancer and other solid tumors study group [J].

Rosen, LS ;

Gordon, D ;

Tchekmedyian, S ;

Yanagihara, R ;

Hirsh, V ;

Krzakowski, M ;

Pawlicki, M ;

de Souza, P ;

Zheng, M ;

Urbanowitz, G ;

Reitsma, D ;

Seaman, JJ .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (16) :3150-3157

[37]

Rosen LS, 2001, CANCER J, V7, P377

[38] Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma - A randomized, double-blind, multicenter, comparative trial [J].

Rosen, LS ;

Gordon, D ;

Kaminski, M ;

Howell, A ;

Belch, A ;

Mackey, J ;

Apffelstaedt, J ;

Hussein, MA ;

Coleman, RE ;

Reitsma, DJ ;

Chen, BL ;

Seaman, JJ .

CANCER, 2003, 98 (08) :1735-1744

[39] Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer [J].

Ross, JR ;

Saunders, Y ;

Edmonds, PM ;

Patel, S ;

Broadley, KE ;

Johnston, SRD .

BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7413) :469-472

[40] Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases [J].

Ruggiero, SL ;

Mehrotra, B ;

Rosenberg, TJ ;

Engroff, SL .

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2004, 62 (05) :527-534

← 1 2 3 4 5 →